Suppr超能文献

COVID-19:一个待破译的谜。

COVID-19: a conundrum to decipher.

机构信息

Department of Anatomy, Biochemistry; All India Institute of Medical Sciences, Nagpur, Maharashtra, India.

出版信息

Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.

Abstract

OBJECTIVE

Recent worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of respiratory coronavirus disease 2019 (COVID-19), is a current, ongoing life-threatening crisis, and international public health emergency. The early diagnosis and management of the disease remains a major challenge. In this review, we aim to summarize the updated epidemiology, causes, clinical manifestation and diagnosis, as well as prevention and control of the novel coronavirus SARS-CoV-2.

MATERIALS AND METHODS

A broad search of the literature was performed in "PubMed" "Medline" "Web of Science", "Google Scholar" and "World Health Organization-WHO" using the keywords "severe acute respiratory syndrome coronavirus", "2019-nCoV", "COVID-19, "SARS", "SARS-CoV-2" "Epidemiology" "Transmission" "Pathogenesis" "Clinical Characteristics". We reviewed and documented the information obtained from literature on epidemiology, pathogenesis and clinical appearances of SARS-CoV-2 infection.

RESULTS

The global cases of COVID-19 as of April 2, 2020, have risen to more than 900,000 and morbidity has reached more than 47,000. The incidence rate for COVID-19 has been predicted to be higher than the previous outbreaks of other coronavirus family members, including those of SARS-CoV and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The main clinical presentation of SARS-CoV-2 infection ranges from asymptomatic stages to severe lower respiratory infection in the form of pneumonia. Most of the patients also presented with fever, cough, sore throat, headache, fatigue, myalgia and breathlessness. Individuals at higher risk for severe illness include elderly people and patients with a weakened immune system or that are suffering from an underlying chronic medical condition like hypertension, diabetes mellitus, cancer, respiratory illness or cardiovascular diseases.

CONCLUSIONS

SARS-Cov-2 has emerged as a worldwide threat, currently affecting 170 countries and territories across the globe. There is still much to be understood regarding SARS-CoV-2 about its virology, epidemiology and clinical management strategies; this knowledge will be essential to both manage the current pandemic and to conceive comprehensive measures to prevent such outbreaks in the future.

摘要

目的

近期全球范围内严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)爆发,该病毒是引发 2019 年冠状病毒病(COVID-19)的病原体,这是当前正在发生的、危及生命的全球公共卫生紧急事件。该疾病的早期诊断和管理仍然是一个主要挑战。在这篇综述中,我们旨在总结新型冠状病毒 SARS-CoV-2 的最新流行病学、病因、临床表现和诊断以及预防和控制措施。

材料和方法

使用“PubMed”、“Medline”、“Web of Science”、“Google Scholar”和“世界卫生组织-WHO”广泛搜索文献,使用关键词“严重急性呼吸综合征冠状病毒”、“2019-nCoV”、“COVID-19”、“SARS”、“SARS-CoV-2”、“流行病学”、“传播”、“发病机制”、“临床特征”。我们综述并记录了从文献中获得的关于 SARS-CoV-2 感染的流行病学、发病机制和临床表现的信息。

结果

截至 2020 年 4 月 2 日,全球 COVID-19 病例已超过 90 万例,发病率超过 47000 例。预计 COVID-19 的发病率将高于冠状病毒家族其他成员(包括 SARS-CoV 和中东呼吸综合征冠状病毒(MERS-CoV))的以往爆发。SARS-CoV-2 感染的主要临床表现从无症状阶段到肺炎形式的严重下呼吸道感染不等。大多数患者还出现发热、咳嗽、咽痛、头痛、乏力、肌痛和呼吸困难。易患重病的人群包括老年人以及免疫系统较弱或患有高血压、糖尿病、癌症、呼吸道疾病或心血管疾病等潜在慢性疾病的患者。

结论

SARS-CoV-2 已成为全球性威胁,目前影响全球 170 个国家和地区。关于其病毒学、流行病学和临床管理策略,我们仍有许多需要了解;这些知识对于管理当前的大流行以及制定未来预防此类爆发的综合措施至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验